The DOI matches its Crossref record; 68 of the 71 references it cites were found in a registry or an index.
Protective role of probiotics and prebiotics in colon cancer
Open accessAbstract
Ingestion of viable probiotics or prebiotics is associated with anticarcinogenic effects, one mechanism of which is the detoxification of genotoxins in the gut. This mechanism was shown experimentally in animals with use of the rat colon carcinogen 1,2-dimethylhydrazine and by determining endpoints that range from tumorigenesis to induction of DNA damage. Because of the complexity of cancer initiation, cancer progression, and the exposure of cancer in the gut, many types of interactions may be envisaged. Notably, some of our newer studies showed that short-lived metabolite mixtures isolated from milk that was fermented with strains of Lactobacillus bulgaricus and Streptococcus thermophilus are more effective in deactivating etiologic risk factors of colon carcinogenesis than are cellular components of microorganisms. Ingestion of prebiotics results in a different spectrum of fermentation products, including the production of high concentrations of short-chain fatty acids. Gut flora, especially after the ingestion of resistant starch, induces the chemopreventive enzyme glutathione transferase pi in the colon of the rat. Together, these factors lead to a reduced load of genotoxic agents in the gut and to an increased production of agents that deactivate toxic components. Butyrate is one such protective agent and is associated with lowering cancer risk. It was recently shown that buytrate may inhibit the genotoxic activity of nitrosamides and hydrogen peroxide in human colon cells. In humans, the ingestion of probiotics leads to the excretion of urine with low concentrations of components that are genotoxic in human colon cells and high concentrations of components that induce oxidized DNA bases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Probiotic bacteria, such as Lactobacilli and Bifidobacteria, produce anticancer substances [113].”
From Marine Natural Products: A Source of Novel Anticancer Drugs (2019) · cites this paper as [113]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
A simple technique for quantitation of low levels of DNA damage in individual cells
Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90265-0 · Cited by 10,828
Campbell, J. M., Fahey, G. C., Jr., & Wolf, B. W. (1997) · Journal of Nutrition · doi:10.1093/jn/127.1.130 · Cited by 720
Polyphenols as cancer chemopreventive agents
Stoner, G. D., & Mukhtar, H. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590822 · Cited by 606
Survival ofLactobacillus species (strain GG) in human gastrointestinal tract
Goldin, B. R., Gorbach, S. L., Saxelin, M., Barakat, S., Gualtieri, L. N., & Salminen, S. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01308354 · Cited by 554
So, F. V., Guthrie, N., Chambers, A. F., Moussa, M., & Carroll, K. K. (1996) · Nutrition and Cancer · doi:10.1080/01635589609514473 · Cited by 492
Rowland, I. R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.281 · Cited by 469
Link‐Amster, H., Rochat, F., Saudan, K.-Y., Mignot, O., & Aeschlimann, J. (1994) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1994.tb00011.x · Cited by 432
Hague, A., Elder, D. J. E., Hicks, D. J., & Paraskeva, C. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600322 · Cited by 414
The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
Goldin, B. R., & Gorbach, S. L. (1984) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.5.756 · Cited by 393
Research works printed but not linked: 3
- Kasper, 1996, Lebendkeime in fermentierten Milchprodukten—ihre Bedeutung für die Prophylaxe und Therapie. (Living bacteria in fermented milk products—their importance for prophylaxis and therapy), Ernahrungsumschau, 43, 40
- Morotomi, 1986, In vitro binding of potent mutagenic pyrolysates, J Natl Cancer Inst, 77, 195
- Tanabe, 1994, Effect of pepsin, trypsin or bile acid on the binding of tryptophane pyrolysates by Lactococcus lactis subsp. lactis T-80, Milchwissenschaft, 49, 438
Cited by
Sorted by citations
Gut flora in health and disease
Guarner, F., & Malagelada, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,480
Dietary modulation of the human colonic microbiota: updating the concept of prebiotics
Gibson, G. R., Probert, H. M., Loo, J. V., Rastall, R. A., & Roberfroid, M. B. (2004) · Nutrition Research Reviews · doi:10.1079/nrr200479 · Cited by 2,539
H OW H OST -M ICROBIAL I NTERACTIONS S HAPE THE N UTRIENT E NVIRONMENT OF THE M AMMALIAN I NTESTINE
Hooper, L. V., Midtvedt, T., & Gordon, J. I. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.011602.092259 · Cited by 1,623
The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome
Markowiak‐Kopeć, P., & Śliżewska, K. (2020) · Nutrients · doi:10.3390/nu12041107 · Cited by 1,314
Functional cultures and health benefits
Shah, N. P. (2007) · International Dairy Journal · doi:10.1016/j.idairyj.2007.01.014 · Cited by 819
Metadata
- Authors
- Wollowski, I., Rechkemmer, G., & Pool-Zobel, B. L.
- Affiliations
- Friedrich Schiller University Jena (DE)
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 73
- Issue
- 2
- Pages
- 451s-455s
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W1940221461
- Cited by
- 560
- References
- 71
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 12 · 2023: 8 · 2022: 16 · 2021: 16 · 2020: 21 · 2019: 18 · 2018: 15 · 2017: 22 · 2016: 32 · 2015: 31 · 2014: 33 · 2013: 39 · 2012: 29
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- OpenAgrar (submittedVersion, other-oa)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, prebiotics, colon cancer, chemoprevention, genotoxicity, 1,2-dimethylhydrazine, short-chain fatty acids, butyrate, glutathione S-transferase pi, resistant starch, Lactobacillus bulgaricus, Streptococcus thermophilus, DNA damage, nitrosamides, hydrogen peroxide, gut microbiota
- MeSH terms
- Animals, Butyrates, Colon, Colonic Neoplasms, Disease Models, Animal, DNA Damage, Fermentation, Glutathione Transferase, Humans, Lactobacillus, Mutation, Streptococcus, Chemoprevention, Probiotics, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review